Nasus Pharma Ltd EFFECT Filing

From the Filing

EDGAR Filing Documents for 9999999995-26-001019 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form EFFECT - Notice of Effectiveness: SEC Accession No. 9999999995-26-001019 Accepted 2026-04-01 00:15:28 Documents 1 Effectiveness Date 2026-03-31 Document Format Files Seq Description Document Type Size 1 primary_doc.html EFFECT 1 primary_doc.xml EFFECT 599 Complete submission text file 9999999995-26-001019.txt 1719 Mailing Address 29 HARAKEVET ST TEL AVIV - YAFO L3 6618003 Business Address 29 HARAKEVET ST TEL AVIV - YAFO L3 6618003 972 54-255-3956 Nasus Pharma Ltd (Filer) CIK : 0002029039 (see all company filings) EIN. : 516022712 | State of Incorp.: L3 | Fiscal Year End: 1231 Type: EFFECT | Act: 33 | File No.: 333-293950 | Film No.: 26824501 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)